Real-life data of direct anticoagulant use, bleeding risk and venous thromboembolism recurrence in chronic thromboembolic pulmonary hypertension patients: an observational retrospective study
Introduction Lifelong anticoagulation is the cornerstone of the chronic thromboembolic pulmonary hypertension (CTEPH) treatment regardless of the additional pulmonary endarterectomy, balloon pulmonary angioplasty, or medical treatment alone. Aim of this study was to evaluate the rate of oral anticoa...
Main Authors: | Sert Sena, Mutlu Bulent, Kocakaya Derya, Kaptan Deniz, Ataş Halil, Erdogan Okan, Yıldızeli Bedrettin |
---|---|
Format: | Article |
Language: | English |
Published: |
SAGE Publishing
2020-02-01
|
Series: | Pulmonary Circulation |
Online Access: | https://doi.org/10.1177/2045894019873545 |
Similar Items
-
Anticoagulant therapy for acute venous thromboembolism
by: Hilal Ermiş, et al.
Published: (2017-09-01) -
New anticoagulants for the prevention of venous thromboembolism
by: Cecilia Becattini, et al.
Published: (2010-04-01) -
Direct oral anticoagulants and venous thromboembolism
by: Massimo Franchini, et al.
Published: (2016-09-01) -
New anticoagulants for the treatment of venous thromboembolism
by: Caio Julio Cesar dos Santos Fernandes, et al.
Published: (2016-04-01) -
Prediction of Major Bleeding in Anticoagulated Patients for Venous Thromboembolism: Comparison of the RIETE and the VTE-BLEED Scores
by: Ramón Lecumberri, et al.
Published: (2021-07-01)